Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Natacyn Generic Name & Formulations
Legal Class
Rx
General Description
Natamycin 5%; oph susp; contains benzalkonium chloride 0.02%.
Pharmacological Class
Antifungal.
How Supplied
Susp—15mL
Manufacturer
Natacyn Indications
Indications
Treatment of fungal blepharitis, conjunctivitis, and keratitis due to susceptible organisms including Fusarium solani keratitis.
Natacyn Dosage and Administration
Adult
Keratitis: initially 1 drop in the conjunctival sac at hourly or two-hourly intervals. May reduce to 1 drop 6–8 times daily after the first 3–4 days. Continue for 14–21 days or until resolution. Reduce dose gradually at 4–7 day intervals to assure replicating organism is eliminated. Blepharitis, conjunctivitis: less frequent initial dosage (4–6 daily applications) may be sufficient.
Children
Not recommended.
Natacyn Contraindications
Not Applicable
Natacyn Boxed Warnings
Not Applicable
Natacyn Warnings/Precautions
Warnings/Precautions
Reevaluate if no improvement after 7–10 days. Monitor at least twice weekly; discontinue if drug toxicity occurs. Pregnancy (Cat. C). Nursing mothers.
Natacyn Pharmacokinetics
See Literature
Natacyn Interactions
Not Applicable
Natacyn Adverse Reactions
Adverse Reactions
Conjunctival chemosis and hyperemia.
Natacyn Clinical Trials
See Literature
Natacyn Note
Not Applicable
Natacyn Patient Counseling
See Literature
